ClinicalTrials.Veeva

Menu

102 Annual Pap Smear Screening Database Maintenance Project

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Cancer
Human Papillomavirus

Study type

Observational

Funder types

Other

Identifiers

NCT02063152
201305072RINC

Details and patient eligibility

About

This study aimed to evaluate the subsequent cancer risks, including gynecological cancers and malignancies at other sites, after the detection of screening positives and the diagnosis for primary cervical cancer.

Enrollment

300,000 estimated patients

Sex

Female

Ages

20 to 130 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Citizens in Taiwan
  • Women who attended screening, or who were diagnosed as cervical cancer
  • Women who did not attend screening for at least 6 years

Exclusion criteria

  • Women died before the follow-up initiation
  • Women who had received hysterectomy before the follow-up initiation

Trial design

300,000 participants in 1 patient group

Entire Taiwan women

Trial contacts and locations

1

Loading...

Central trial contact

Hui-Chi Chen, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems